Compounds > eicosapentaenoic acid ethyl ester

eicosapentaenoic acid ethyl ester and cardiovascular agents

eicosapentaenoic acid ethyl ester has been researched along with cardiovascular agents in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Tatsuno, I	1
Kasono, K; Nobe, K; Ohtake, K; Takenouchi, Y	1
Agarwala, A; Al Rifai, M; Hussain, A; Jia, X; Martin, S; Virani, SS	1

Reviews

2 review(s) available for eicosapentaenoic acid ethyl ester and cardiovascular agents

Article	Year
Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia. Expert review of cardiovascular therapy, 2014, Volume: 12, Issue:11 Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Humans; Hypertriglyceridemia; Platelet Aggregation Inhibitors	2014
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well. Current atherosclerosis reports, 2020, 10-03, Volume: 22, Issue:12 Topics: Benzhydryl Compounds; Betacoronavirus; Cardiology; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Congresses as Topic; Coronavirus Infections; COVID-19; Eicosapentaenoic Acid; Europe; Glucosides; Humans; Lipid Regulating Agents; Oligonucleotides; Pandemics; Pneumonia, Viral; SARS-CoV-2; Societies, Medical; Telecommunications	2020

Article

Year

Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia.

Expert review of cardiovascular therapy, 2014, Volume: 12, Issue:11

Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Humans; Hypertriglyceridemia; Platelet Aggregation Inhibitors

2014

Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well.

Current atherosclerosis reports, 2020, 10-03, Volume: 22, Issue:12

Topics: Benzhydryl Compounds; Betacoronavirus; Cardiology; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Congresses as Topic; Coronavirus Infections; COVID-19; Eicosapentaenoic Acid; Europe; Glucosides; Humans; Lipid Regulating Agents; Oligonucleotides; Pandemics; Pneumonia, Viral; SARS-CoV-2; Societies, Medical; Telecommunications

2020

Other Studies

1 other study(ies) available for eicosapentaenoic acid ethyl ester and cardiovascular agents

Article	Year
Eicosapentaenoic acid ethyl ester improves endothelial dysfunction in type 2 diabetic mice. Lipids in health and disease, 2018, May-22, Volume: 17, Issue:1 Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Glucose; Cardiovascular Agents; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Eicosapentaenoic Acid; Endothelium, Vascular; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Contraction; Nitroprusside; Phenylephrine; Tissue Culture Techniques; Vasodilation	2018

Article

Year

Eicosapentaenoic acid ethyl ester improves endothelial dysfunction in type 2 diabetic mice.

Lipids in health and disease, 2018, May-22, Volume: 17, Issue:1

Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Glucose; Cardiovascular Agents; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Eicosapentaenoic Acid; Endothelium, Vascular; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Contraction; Nitroprusside; Phenylephrine; Tissue Culture Techniques; Vasodilation

2018